Wall Street Zen upgraded shares of Haoxi Health Technology (NASDAQ:HAO – Free Report) to a hold rating in a research report report published on Saturday morning.
Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Haoxi Health Technology in a research note on Friday, July 17th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company has an average rating of “Sell”.
Haoxi Health Technology Stock Performance
Haoxi Health Technology Company Profile
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo.
Read More
- Five stocks we like better than Haoxi Health Technology
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for Haoxi Health Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haoxi Health Technology and related companies with MarketBeat.com's FREE daily email newsletter.
